Answers are grounded in this paper and cite their sources.
Eleven commercial mushroom products sourced from online resellers (ten labelled for veterinary use and one labelled for human use) were subjected to simple quantitative and qualitative polysaccharide analysis methods to differentiate products containing only mushrooms (the fruiting bodies of the fungal life-cycle) from those that include the whole solid fermentation resulting from the fungal mycelium of cereal grain. The therapeutic benefits of fungi are often attributed to their β-glucan content, which, unlike cereal grain β-glucans, is uniquely characterized by 1,3–1,6 β-glycosidic linkages. Fungal polysaccharide markers were used to distinguish mushroom-containing products from grain-based mycelial products in this study, which highlighted the compositional variability in marketplace products. These products were subjected to a multifaceted analytical approach by enzymatic quantification of α- and β-glucans and starch, and Lugol’s iodine staining for starch detection. The resulting analyses identified two distinct product profiles: (1) polysaccharide profiles consistent with mushrooms, exhibiting high β-glucan and low α-glucan content and (2) products consistent with fermentation of cereal grains by fungal mycelium that have lower levels of β-glucans, higher levels of α-glucans, and a strong positive iodine-starch test. This study proposes objective, composition-based criteria, derived from the products analyzed, for differentiation of these product profiles; the polysaccharide profiles of some products labelled as mushroom-derived were consistent with mycelium-fermented grain rather than with mushrooms. This method can be adapted to assess other fungal-derived products and to help verify the label claims of mushroom-based veterinary products.
No takes yet. Share an insight, caveat, or question.
Atuahene et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: